Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment (Q39031833)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 March 2015

Language	Label	Description	Also known as
English	Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment	scientific article published on 9 March 2015

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment (English)

1 reference

Europe PubMed Central

8 September 2017

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Jean-Pierre Bourquin

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Arndt Borkhardt

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Christina Peters

6

object named as

C Peters

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

C Eckert

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

N Hagedorn

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

L Sramkova

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

G Mann

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

R Panzer-Grümayer

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

T Klingebiel

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

G Cario

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

J Alten

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

G Escherich

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

K Astrahantseff

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

K Seeger

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

G Henze

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

A von Stackelberg

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

9 March 2015

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1648-1655

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25748682%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

https://scigraph.springernature.com/pub.10.1038/leu.2015.59

0 references

Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Childhood acute lymphoblastic leukaemia and relapse

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Bone-marrow relapse in paediatric acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Allogeneic transplantation for childhood ALL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Allogeneic hematopoietic SCT in children with ALL: current concepts of ongoing prospective SCT trials.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.59

21 January 2018

The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL).

1 reference

https://pubmed.ncbi.nlm.nih.gov/25748682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: inv

1 reference

https://pubmed.ncbi.nlm.nih.gov/25748682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations

1 reference

https://pubmed.ncbi.nlm.nih.gov/25748682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25748682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage

1 reference

https://pubmed.ncbi.nlm.nih.gov/25748682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

1 reference

https://pubmed.ncbi.nlm.nih.gov/25748682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25748682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Real-Time PCR to Detect Minimal Residual Disease in Childhood ALL

1 reference

https://pubmed.ncbi.nlm.nih.gov/25748682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25748682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25748682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25748682

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39031833&oldid=2098352921"